RxDoctor Payments Data

Eduardo Hernandez

Hematology & Oncology · San Juan, PRNPI 1780049650

Payments from drug & device makers

$7,045in general payments, 2019–2025

Across 223 payments — averaging $31.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$2K
  • PBG Puerto Rico LLC$736
  • Johnson & Johnson$711
  • Amgen$614
  • AbbVie$547
  • AstraZeneca$449
  • plus $2K from 27 others

What the payments were for

  • Speaking & faculty fees$1,20017%
  • Food & beverage$5,56079%
  • Education$2854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,045 in reported general payments places this provider in the 35th percentile of 138 hematology & oncology providers in Puerto Rico.

See all hematology & oncology providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide11$155,403
EliquisApixaban40$25,138
RetacritEpoetin Alfa-Epbx21$11,098
Sucralfate25$3,820
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen46$1,090
Dexamethasone32$764
Bicalutamide22$753
Hydroxyurea18$405
Ondansetron Hcl22$334
LoperamideLoperamide Hcl11$267
Anastrozole17$205
Prednisone36$179
Montelukast Sodium15$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi$51$155,40311 claims
PfizerEliquis, Retacrit$66$36,23661 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 138 hematology & oncology providers in Puerto Rico.

Other hematology & oncology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →